Shareholders Hua Jie Investment and Shanghai Panxin have collectively reduced their holdings by 2.0115 million shares in Shanghai OPM Biosciences (688293.SH).

11/02/2025

GMT Eight

Shanghai OPM Biosciences (688293.SH) announced that shareholders Huajie Investment and Shanghai Panxin have cumulatively reduced their holdings by 201.15 million shares.

Tiange (01980) spent HKD11,000 to repurchase 200,000 shares on February 11th.

CITIC SEC: Gold breaks new high again, what will be the future trend?

Contact: contact@gmteight.com

Shareholders Hua Jie Investment and Shanghai Panxin have collectively reduced their holdings by 2.0115 million shares in Shanghai OPM Biosciences (688293.SH).

RECOMMEND

Pre-market report of A-share market | MSCI China flagship index adjustment, Apple and Alibaba collaborate on artificial intelligence.

ASCENTAGE-B (06855) issued 3.7406 million shares on February 11th by exercising the oversubscription rights under the underwriting agreement.

Super Micro Computer, Inc. (SMCI.US) The preliminary performance in Q2 is weak but the revenue in FY 2026 is expected to exceed $40 billion, far beyond expectations.